Association between skeletal muscle mitochondrial dysfunction and insulin resistance in patients with rheumatoid arthritis: a case-control study.


Journal

Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438

Informations de publication

Date de publication:
20 05 2023
Historique:
received: 19 04 2023
accepted: 09 05 2023
medline: 22 5 2023
pubmed: 21 5 2023
entrez: 20 5 2023
Statut: epublish

Résumé

Insulin resistance affects a substantial proportion of patients with rheumatoid arthritis (RA). Skeletal muscle mitochondrial dysfunction results in the accumulation of lipid intermediates that interfere with insulin signaling. We therefore sought to determine if lower oxidative phosphorylation and muscle mitochondrial content are associated with insulin resistance in patients with RA. This was a cross-sectional prospective study of RA patients. Matsuda index from the glucose tolerance test was used to estimate insulin sensitivity. Mitochondrial content was measured by citrate synthase (CS) activity in snap-frozen muscle samples. Mitochondrial function was measured by using high-resolution respirometry of permeabilized muscle fibers and electron transport chain complex IV enzyme kinetics in isolated mitochondrial subpopulations. RA participants demonstrated lower insulin sensitivity as measured by the Matsuda index compared to controls [median 3.95 IQR (2.33, 5.64) vs. 7.17 (5.83, 7.75), p = 0.02]. There was lower muscle mitochondrial content among RA vs. controls [median 60 mU/mg IQR (45, 80) vs. 79 mU/mg (65, 97), p = 0.03]. Notably, OxPhos normalized to mitochondrial content was higher among RA vs. controls [mean difference (95% CI) = 0.14 (0.02, 0.26), p = 0.03], indicating a possible compensatory mechanism for lower mitochondrial content or lipid overload. Among RA participants, the activity of muscle CS activity was not correlated with the Matsuda index (ρ =  - 0.05, p = 0.84), but it was positively correlated with self-reported (IPAQ) total MET-minutes/week (ρ = 0.44, p = 0.03) and Actigraph-measured time on physical activity (MET rate) (ρ = 0.47, p = 0.03). Mitochondrial content and function were not associated with insulin sensitivity among participants with RA. However, our study demonstrates a significant association between muscle mitochondrial content and physical activity level, highlighting the potential for future exercise interventions that enhance mitochondrial efficiency in RA patients.

Sections du résumé

BACKGROUND
Insulin resistance affects a substantial proportion of patients with rheumatoid arthritis (RA). Skeletal muscle mitochondrial dysfunction results in the accumulation of lipid intermediates that interfere with insulin signaling. We therefore sought to determine if lower oxidative phosphorylation and muscle mitochondrial content are associated with insulin resistance in patients with RA.
METHODS
This was a cross-sectional prospective study of RA patients. Matsuda index from the glucose tolerance test was used to estimate insulin sensitivity. Mitochondrial content was measured by citrate synthase (CS) activity in snap-frozen muscle samples. Mitochondrial function was measured by using high-resolution respirometry of permeabilized muscle fibers and electron transport chain complex IV enzyme kinetics in isolated mitochondrial subpopulations.
RESULTS
RA participants demonstrated lower insulin sensitivity as measured by the Matsuda index compared to controls [median 3.95 IQR (2.33, 5.64) vs. 7.17 (5.83, 7.75), p = 0.02]. There was lower muscle mitochondrial content among RA vs. controls [median 60 mU/mg IQR (45, 80) vs. 79 mU/mg (65, 97), p = 0.03]. Notably, OxPhos normalized to mitochondrial content was higher among RA vs. controls [mean difference (95% CI) = 0.14 (0.02, 0.26), p = 0.03], indicating a possible compensatory mechanism for lower mitochondrial content or lipid overload. Among RA participants, the activity of muscle CS activity was not correlated with the Matsuda index (ρ =  - 0.05, p = 0.84), but it was positively correlated with self-reported (IPAQ) total MET-minutes/week (ρ = 0.44, p = 0.03) and Actigraph-measured time on physical activity (MET rate) (ρ = 0.47, p = 0.03).
CONCLUSIONS
Mitochondrial content and function were not associated with insulin sensitivity among participants with RA. However, our study demonstrates a significant association between muscle mitochondrial content and physical activity level, highlighting the potential for future exercise interventions that enhance mitochondrial efficiency in RA patients.

Identifiants

pubmed: 37210569
doi: 10.1186/s13075-023-03065-z
pii: 10.1186/s13075-023-03065-z
pmc: PMC10199606
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

85

Subventions

Organisme : NIAMS NIH HHS
ID : K23 AR068450
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002733
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003096
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK079626
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Med Sci Sports Exerc. 2017 Dec;49(12):2414-2421
pubmed: 28737531
J Clin Invest. 2005 Dec;115(12):3587-93
pubmed: 16284649
Nat Protoc. 2008;3(6):965-76
pubmed: 18536644
Muscle Nerve. 2011 May;43(5):717-25
pubmed: 21462204
Proc Natl Acad Sci U S A. 1989 Mar;86(5):1583-7
pubmed: 2922400
Diabetes. 2002 Jul;51(7):2005-11
pubmed: 12086926
Scand J Rheumatol. 1975;4(4):197-204
pubmed: 1198073
Arthritis Rheum. 2008 Jan 15;59(1):42-50
pubmed: 18163412
N Engl J Med. 2004 Feb 12;350(7):664-71
pubmed: 14960743
J Rheumatol. 2021 Mar;48(3):339-347
pubmed: 32541071
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Arthritis Res Ther. 2011;13(5):R159
pubmed: 21959060
Arthritis Res Ther. 2021 Mar 26;23(1):95
pubmed: 33771189
J Physiol. 2012 Jul 15;590(14):3349-60
pubmed: 22586215
Diabetes Care. 2008 Aug;31(8):1644-9
pubmed: 18487474
Diabetes. 2002 Oct;51(10):2944-50
pubmed: 12351431
J Appl Physiol (1985). 2019 Dec 1;127(6):1562-1568
pubmed: 31556836
Diabetes. 2007 Jun;56(6):1592-9
pubmed: 17351150
J Physiol. 2021 Feb;599(3):803-817
pubmed: 31674658
Arthritis Rheum. 2005 Nov;52(11):3413-23
pubmed: 16255018
Arthritis Rheumatol. 2015 Mar;67(3):626-36
pubmed: 25504899
Front Physiol. 2016 Oct 06;7:446
pubmed: 27766080
Am J Physiol Cell Physiol. 2005 May;288(5):C1074-82
pubmed: 15647392
J Appl Physiol (1985). 2014 Mar 1;116(5):582-92
pubmed: 24408997
Ultrastruct Pathol. 2000 May-Jun;24(3):151-6
pubmed: 10914426
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158574
pubmed: 31747539
Arthritis Care Res (Hoboken). 2013 Jul;65(7):1166-76
pubmed: 23335505
Biochem J. 1969 Sep;114(3):597-610
pubmed: 5820645
Rheumatology (Oxford). 2022 May 30;61(6):2285-2294
pubmed: 34559201
Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):7343-7348
pubmed: 28652350
J Appl Physiol (1985). 2005 Dec;99(6):2149-58
pubmed: 16051712
Integr Comp Biol. 2018 Sep 1;58(3):486-494
pubmed: 29982616
Arthritis Res Ther. 2021 Jul 10;23(1):187
pubmed: 34246305
Innate Immun. 2012 Feb;18(1):25-34
pubmed: 21088047
Science. 2003 May 16;300(5622):1140-2
pubmed: 12750520
Diabetes Care. 2018 Oct;41(10):2245-2254
pubmed: 30072402
Int J Obes Relat Metab Disord. 2002 Aug;26(8):1110-7
pubmed: 12119577
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
Diabetes. 2005 Jan;54(1):8-14
pubmed: 15616005
Front Physiol. 2018 Oct 31;9:1451
pubmed: 30429793
Rheumatology (Oxford). 2015 Dec;54(12):2215-20
pubmed: 26209790
Diabetes. 2006 Dec;55 Suppl 2:S9-S15
pubmed: 17130651
Atherosclerosis. 2008 Feb;196(2):756-63
pubmed: 17266963
PLoS One. 2014 Aug 14;9(8):e103044
pubmed: 25121500
Arthritis Rheum. 1995 Jan;38(1):44-8
pubmed: 7818570
Arthritis Rheum. 2008 Jul;58(7):2105-12
pubmed: 18576352
Public Health Nutr. 2006 Sep;9(6):755-62
pubmed: 16925881
Diabetes Care. 2007 Jan;30(1):89-94
pubmed: 17192339
Rheumatology (Oxford). 2021 Oct 2;60(10):4548-4557
pubmed: 33493311
Diabetes. 2006 Dec;55(12):3309-19
pubmed: 17130474
Diabetes. 2007 Aug;56(8):2085-92
pubmed: 17519422
J Appl Physiol (1985). 2006 Aug;101(2):531-44
pubmed: 16614355

Auteurs

Douglas R Moellering (DR)

Department of Nutrition Sciences, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, USA.

Kelley Smith-Johnston (K)

Department of Nutrition Sciences, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, USA.

Christian Kelley (C)

Center for Exercise Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

Melissa J Sammy (MJ)

Department of Nutrition Sciences, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, USA.

Jason Benedict (J)

Department of Biomedical Bioinformatics, College of Medicine, The Ohio State University, Columbus, OH, USA.

Guy Brock (G)

Department of Biomedical Bioinformatics, College of Medicine, The Ohio State University, Columbus, OH, USA.

Jillian Johnson (J)

Department of Surgery, College of Medicine, The Ohio State University, Columbus, OH, USA.

Kedryn K Baskin (KK)

Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA.

Wael N Jarjour (WN)

Division of Rheumatology and Immunology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.

Martha A Belury (MA)

Department of Human Sciences, College of Education and Human Ecology, The Ohio State University, Columbus, OH, USA.

Peter J Reiser (PJ)

Division of Biosciences, College of Dentistry, The Ohio State University, Columbus, OH, USA.

Prabhakara R Nagareddy (PR)

Department of Surgery, College of Medicine, The Ohio State University, Columbus, OH, USA.

Beatriz Y Hanaoka (BY)

Division of Rheumatology and Immunology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA. Beatriz.Hanaoka@osumc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH